Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method

Journal of Controlled Release

Volumn 98, Issue 2, 2004, Pages 317-323

  Kogure, Kentaro ^a   Moriguchi, Rumiko ^b   Sasaki, Kentaro ^b   Ueno, Masaharu ^c   Futaki, Shiroh ^d   Harashima, Hideyoshi ^a,b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Lipid film hydration; Multifunctional envelope type nano device; Non viral vector; Stearyl octaarginine

Indexed keywords

CONDENSATION; DENSITY (OPTICAL); DNA; DRUG PRODUCTS; GENES; HYDRATION; SUGAR (SUCROSE);

LIPID FILM HYDRATION; POLYCATIONS;

LIPIDS;

ARGININE DERIVATIVE; CHOLESTEROL HYDROGEN SUCCINATE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPID; PLASMID DNA; POLYLYSINE; STEARYL OCTAARGININE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DNA BINDING; DNA TRANSFECTION; HYDRATION; INSTRUMENTATION; LIPID BILAYER; MOUSE; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POLYMERIZATION; PRIORITY JOURNAL; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TITRIMETRY; ULTRASOUND;

ANIMALS; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL ESTERS; ELECTROPHORESIS, AGAR GEL; ELECTROSTATICS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FREEZE FRACTURING; GENE THERAPY; GENE TRANSFER TECHNIQUES; LIPIDS; LUCIFERASES; MICE; MICROSCOPY, ELECTRON; NANOSTRUCTURES; NANOTECHNOLOGY; NIH 3T3 CELLS; OLIGOPEPTIDES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; POLYLYSINE; RHODAMINES; SONICATION; STEARATES; TRANSFECTION;

EID: 3242657221     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.04.024     Document Type: Article

References (13)

1. Thomas M., Klibanov A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 62:2003;27-34
2. Templeton N.S. Cationic liposome-mediated gene delivery in vivo. Biosci. Rep. 22:2002;283-295
3. Takakura Y., Nishikawa M., Yamashita F., Hashida M. Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery. J. Drug Target. 10:2002;99-104
4. Wheeler J.J., Palmer L., Ossanlou M., MacLachlan I., Graham R.W., Zhang Y.P., Hope M.J., Scherrer P., Cullis P.R. Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. 6:1999;271-281
5. Tam P., Monck M., Lee D., Ludkovski O., Leng E.C., Clow K., Stark H., Scherrer P., Graham R.W., Cullis P.R. Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther. 7:2000;1867-1874
6. Saravolac E.G., Ludkovski O., Skirrow R., Ossanlou M., Zhang Y.P., Giesbrecht C., Thompson J., Thomas S., Stark H., Cullis P.R., Sherrer P. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optical transfection activity. J. Drug Target. 7:2000;423-437
7. K. Kamiya, H. Akita, H. Harashima, Pharmacokinetic and pharmacodynamic considerations in gene therapy, Drug Discov. Today, in press.
8. Kamiya K., Tsuchiya H., Yamazaki J., Harashima H. Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv. Drug Deliv. Rev. 52:2001;153-164
9. M. Tanimoto, H. Kamiya, N. Minakawa, A. Matsuda, H. Harashima, No enhancement of nuclear entry by direct conjugation of nuclear localization signal peptide to linearized DNA, Bioconjug. Chem., in press.
10. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., Harashima H., Sugiura Y. Stearylated arginine-rich peptides: a new class of transfection system. Bioconjug. Chem. 12:2001;1005-1011
11. Sriwongsitanont S., Ueno M. Physicochemical properties of PEG-grafted liposomes. Chem. Pharm. Bull. 50:2002;1238-1244
12. Leifert J.A., Whitton J.L. "Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms. Mol. Ther. 8:2003;13-20
13. Khalil I.A., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., Harashima H. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther. 11:2004;636-644